Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Sex differences in pharmacological cardioversion in patients with atrial fibrillation — Yang Liu (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Sex differences in pharmacological cardioversion in patients with atrial fibrillation
Shared by
Professor Gregory Lip
University of Liverpool
Sex differences in pharmacological cardioversion in patients with atrial fibrillation
Letter
2023
en
Authors
YL
Yang Liu
Professor Gregory Lip
University of Liverpool
Abstract
1 min read
With an increasing incidence and prevalence worldwide, atrial fibrillation (AF) representing a
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2017
Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus
Alexandra Moss
,
Gerasimos Dimitropoulos
,
Derek Connolly
,
Professor Gregory Lip
Article
2024
Global voices on atrial fibrillation care in China
Mingfang Li
,
Minglong Chen
,
Yutao Guo
,
Professor Gregory Lip
Article
2020
Epidemiology of Atrial Fibrillation in the 21st Century
Jelena Kornej
,
Christin S. Börschel
,
Emelia Benjamin
,
Renate B. Schnabel
Article
2019
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2
Gaurav Panchal
,
Maria Mahmood
,
Professor Gregory Lip
Article
2019
Management of atrial fibrillation: easy as ABC
Maria Mahmood
,
Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.